Perceptive Advisors is a hedge fund sponsor with a strong focus on the life sciences sector, investing in promising healthcare technologies. The firm typically participates in various investment stages, including Series A, B, C, and later rounds, with a significant number of investments in Series B and C rounds. Their investment strategy is centered on identifying and supporting breakthrough innovations in healthcare that have the potential to make a substantial impact on the industry.

Notable portfolio companies include 4D Molecular Therapeutics, Absci, Alector, Beam Therapeutics, and BridgeBio Pharma. The firm is led by a skilled team with deep expertise in the biomedical landscape, guiding companies from discovery to distribution. Perceptive Advisors offers unique value-add services, leveraging their extensive industry knowledge and network to support the growth and success of their portfolio companies. Their investment philosophy emphasizes long-term potential and transformative impact in the healthcare sector.